Xianzhi Lin, PhD

Xianzhi (Andrew) Lin, PhD, is a postdoctoral scientist in the Cedars-Sinai Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute. Dr. Lin received his bachelor’s diploma in Bioengineering from the Kunming University of Science and Technology in 2004, and a PhD in Microbiology from Institut Pasteur of Shanghai Chinese Academy of Sciences in 2012. Before joining Dr. Kate Lawrenson’s lab in November 2015, he worked as a postdoctoral researcher at the University of California, Los Angeles with Dr. Grace Xiao studying the molecular mechanisms of RNA regulation – including alternative splicing, RNA editing, and RNA degradation. Currently, his research focuses on elucidating the mechanism of long noncoding RNAs in the initiation and/or development of ovarian cancers.